[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Nuclear Receptor ROR Gamma Market Report 2017

December 2017 | 108 pages | ID: U1F63A6A612EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Nuclear Receptor ROR Gamma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Nuclear Receptor ROR Gamma in these regions, from 2012 to 2022 (forecast).
United States Nuclear Receptor ROR Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR Gamma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Genfit SA
  • GlaxoSmithKline Plc
  • Aurigene Discovery Technologies Ltd
  • Beijing Hanmi Pharmaceutical Co Ltd
  • Biogen Inc
  • AbbVie Inc
  • Advinus Therapeutics Ltd
  • Brickell Biotech Inc
  • Pfizer Inc
  • Phenex Pharmaceuticals AG
  • Reata Pharmaceuticals Inc
  • Bristol-Myers Squibb Company
  • Celgene Corp
  • Eli Lilly and Company
  • Glenmark Pharmaceuticals Ltd
  • Lead Pharma Holding BV
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • BBI-6000
  • GRC-39815Action
  • R&D Progress
  • GSK-2981278
  • IMU-366
  • INV-17
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Axial Spondyloarthritis
  • Breast Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Nuclear Receptor ROR Gamma Market Report 2017

1 NUCLEAR RECEPTOR ROR GAMMA OVERVIEW

1.1 Product Overview and Scope of Nuclear Receptor ROR Gamma
1.2 Classification of Nuclear Receptor ROR Gamma by Product Category
  1.2.1 United States Nuclear Receptor ROR Gamma Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Nuclear Receptor ROR Gamma Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 BBI-6000
  1.2.4 GRC-39815Action
  1.2.5 R&D Progress
  1.2.6 GSK-2981278
  1.2.7 IMU-366
  1.2.8 INV-17
  1.2.9 Others
1.3 United States Nuclear Receptor ROR Gamma Market by Application/End Users
  1.3.1 United States Nuclear Receptor ROR Gamma Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chronic Obstructive Pulmonary Disease
  1.3.3 Asthma
  1.3.4 Axial Spondyloarthritis
  1.3.5 Breast Cancer
  1.3.6 Others
1.4 United States Nuclear Receptor ROR Gamma Market by Region
  1.4.1 United States Nuclear Receptor ROR Gamma Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
  1.4.3 Southwest Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
  1.4.5 New England Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
  1.4.6 The South Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
  1.4.7 The Midwest Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Nuclear Receptor ROR Gamma (2012-2022)
  1.5.1 United States Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2022)
  1.5.2 United States Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2022)

2 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Nuclear Receptor ROR Gamma Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Nuclear Receptor ROR Gamma Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Nuclear Receptor ROR Gamma Average Price by Players/Suppliers (2012-2017)
2.4 United States Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
  2.4.1 United States Nuclear Receptor ROR Gamma Market Concentration Rate
  2.4.2 United States Nuclear Receptor ROR Gamma Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Region (2012-2017)
3.2 United States Nuclear Receptor ROR Gamma Revenue and Market Share by Region (2012-2017)
3.3 United States Nuclear Receptor ROR Gamma Price by Region (2012-2017)

4 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Nuclear Receptor ROR Gamma Revenue and Market Share by Type (2012-2017)
4.3 United States Nuclear Receptor ROR Gamma Price by Type (2012-2017)
4.4 United States Nuclear Receptor ROR Gamma Sales Growth Rate by Type (2012-2017)

5 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Application (2012-2017)
5.2 United States Nuclear Receptor ROR Gamma Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Genfit SA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline Plc
  6.2.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Aurigene Discovery Technologies Ltd
  6.3.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Beijing Hanmi Pharmaceutical Co Ltd
  6.4.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Biogen Inc
  6.5.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 AbbVie Inc
  6.6.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Advinus Therapeutics Ltd
  6.7.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Brickell Biotech Inc
  6.8.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Pfizer Inc
  6.9.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Phenex Pharmaceuticals AG
  6.10.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Reata Pharmaceuticals Inc
6.12 Bristol-Myers Squibb Company
6.13 Celgene Corp
6.14 Eli Lilly and Company
6.15 Glenmark Pharmaceuticals Ltd
6.16 Lead Pharma Holding BV

7 NUCLEAR RECEPTOR ROR GAMMA MANUFACTURING COST ANALYSIS

7.1 Nuclear Receptor ROR Gamma Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Nuclear Receptor ROR Gamma Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Nuclear Receptor ROR Gamma Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES NUCLEAR RECEPTOR ROR GAMMA MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Nuclear Receptor ROR Gamma Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Type (2017-2022)
11.3 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Application (2017-2022)
11.4 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Receptor ROR Gamma
Figure United States Nuclear Receptor ROR Gamma Market Size (K Pcs) by Type (2012-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume Market Share by Type (Product Category) in 2016
Figure BBI-6000 Product Picture
Figure GRC-39815Action Product Picture
Figure R&D Progress Product Picture
Figure GSK-2981278 Product Picture
Figure IMU-366 Product Picture
Figure INV-17 Product Picture
Figure Others Product Picture
Figure United States Nuclear Receptor ROR Gamma Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Nuclear Receptor ROR Gamma by Application in 2016
Figure Chronic Obstructive Pulmonary Disease Examples
Table Key Downstream Customer in Chronic Obstructive Pulmonary Disease
Figure Asthma Examples
Table Key Downstream Customer in Asthma
Figure Axial Spondyloarthritis Examples
Table Key Downstream Customer in Axial Spondyloarthritis
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Nuclear Receptor ROR Gamma Market Size (Million USD) by Region (2012-2022)
Figure The West Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Receptor ROR Gamma Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Nuclear Receptor ROR Gamma Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Receptor ROR Gamma Sales Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR Gamma Sales Share by Players/Suppliers
Figure United States Nuclear Receptor ROR Gamma Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Nuclear Receptor ROR Gamma Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Nuclear Receptor ROR Gamma Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Nuclear Receptor ROR Gamma Revenue Share by Players/Suppliers
Figure 2017 United States Nuclear Receptor ROR Gamma Revenue Share by Players/Suppliers
Table United States Market Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Nuclear Receptor ROR Gamma Market Share of Top 3 Players/Suppliers
Figure United States Nuclear Receptor ROR Gamma Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Nuclear Receptor ROR Gamma Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Nuclear Receptor ROR Gamma Product Category
Table United States Nuclear Receptor ROR Gamma Sales (K Pcs) by Region (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales Share by Region (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Share by Region (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Market Share by Region in 2016
Table United States Nuclear Receptor ROR Gamma Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Nuclear Receptor ROR Gamma Revenue Share by Region (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Revenue Market Share by Region (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Revenue Market Share by Region in 2016
Table United States Nuclear Receptor ROR Gamma Price (USD/Pcs) by Region (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales Share by Type (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Share by Type (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Market Share by Type in 2016
Table United States Nuclear Receptor ROR Gamma Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Nuclear Receptor ROR Gamma Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Nuclear Receptor ROR Gamma by Type (2012-2017)
Figure Revenue Market Share of Nuclear Receptor ROR Gamma by Type in 2016
Table United States Nuclear Receptor ROR Gamma Price (USD/Pcs) by Types (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Growth Rate by Type (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2012-2017)
Table United States Nuclear Receptor ROR Gamma Sales Market Share by Application (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Market Share by Application (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Market Share by Application in 2016
Table United States Nuclear Receptor ROR Gamma Sales Growth Rate by Application (2012-2017)
Figure United States Nuclear Receptor ROR Gamma Sales Growth Rate by Application (2012-2017)
Table Genfit SA Basic Information List
Table Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Genfit SA Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Aurigene Discovery Technologies Ltd Basic Information List
Table Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Beijing Hanmi Pharmaceutical Co Ltd Basic Information List
Table Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Biogen Inc Basic Information List
Table Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Biogen Inc Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table AbbVie Inc Basic Information List
Table AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure AbbVie Inc Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Advinus Therapeutics Ltd Basic Information List
Table Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Brickell Biotech Inc Basic Information List
Table Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Brickell Biotech Inc Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Pfizer Inc Basic Information List
Table Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Pfizer Inc Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Phenex Pharmaceuticals AG Basic Information List
Table Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales Growth Rate (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales Market Share in United States (2012-2017)
Figure Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Revenue Market Share in United States (2012-2017)
Table Reata Pharmaceuticals Inc Basic Information List
Table Bristol-Myers Squibb Company Basic Information List
Table Celgene Corp Basic Information List
Table Eli Lilly and Company Basic Information List
Table Glenmark Pharmaceuticals Ltd Basic Information List
Table Lead Pharma Holding BV Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Receptor ROR Gamma
Figure Manufacturing Process Analysis of Nuclear Receptor ROR Gamma
Figure Nuclear Receptor ROR Gamma Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Receptor ROR Gamma Major Players/Suppliers in 2016
Table Major Buyers of Nuclear Receptor ROR Gamma
Table Distributors/Traders List
Figure United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Nuclear Receptor ROR Gamma Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Nuclear Receptor ROR Gamma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume Share Forecast by Region (2017-2022)
Figure United States Nuclear Receptor ROR Gamma Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories